HIV DRUG RESISTANCE REPORT 2017 – WHO – CDC – The Global Fund 82 pags.

August 7, 2017 at 8:03 am

Antimicrobial resistance (AMR) is a growing global public health threat, which urgently requires collective action to ensure effective prevention and treatment of infections. Minimizing the emergence and transmission of HIV drug resistance (HIVDR) is a critical aspect of the broader global response to AMR. Prevention, monitoring and response to HIVDR is key to building and sustaining gains in HIV treatment scale-up, and achieving the global 90-90-90 targets for treatment. These widely adopted targets reflect the global community’s commitment to expanding access to antiretroviral therapy (ART) including: diagnosing 90% of all people with HIV infection; providing treatment to 90% of those diagnosed; and ensuring 90% of people on treatment achieve virological suppression, by 2020. By the end of 2016, 70% of people living with HIV (PLHIV) were diagnosed,77% of those who knew their HIV status received ART, and 82% of those on treatment were virally suppressed…

PDF

http://apps.who.int/iris/bitstream/10665/255896/1/9789241512831-eng.pdf

Advertisements

Entry filed under: Antirretrovirales, Epidemiología, HIV/SIDA, HIV/SIDA HAART, HIV/SIDA Laboratorio, Infecciones virales, Metodos diagnosticos, REPORTS, Update.

BACTERIAS ANEROBIAS 305 págs 2017-07 Guidelines for the managing advanced HIV disease and rapid initiation of antiretroviral therapy. WHO 56 pags


Calendar

August 2017
M T W T F S S
« Jul    
 123456
78910111213
14151617181920
21222324252627
28293031  

Most Recent Posts


%d bloggers like this: